A Randomised, Single-blind, Placebo-controlled, Two-centre Phase I Study in Healthy Volunteers to Assess the Safety, Tolerability and Pharmacokinetics of AZD8329 After Single Ascending Oral Doses.
Phase of Trial: Phase I
Latest Information Update: 31 Aug 2010
At a glance
- Drugs AZD 8329 (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Adverse reactions
- 26 Aug 2010 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov.
- 13 May 2010 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.
- 08 May 2010 Planned end date (Aug 2010) added as reported by ClinicalTrials.gov.